3547 results for «239»

Filter By

3547 results

Challenging STEMI cases

22 Sep 2023 – From AICT-AsiaPCR 2023

Dive into complex STEMI cases in this session, featuring presentations on unusual coronary anomalies, the challenges of long diffuse lesions, innovative approaches like intracoronary arterial retrograde thrombolysis, an intriguing case of acute coronary syndrome with uncommon causes, and much more!

Challenging STEMI cases

Challenges in calcified lesions

21 Sep 2023 – From AICT-AsiaPCR 2023

Explore a variety of challenging cases in this session, from the perplexing uncrossable STEMI to the specialized "Blocked" balloon anchoring technique, the unique challenges of calcified lesions in elderly patients to the debulking of a calcified nodule within the left circumflex ostium through the stent strut,...

Challenges in calcified lesions

Welcome to PCR Rio Valves 2025

11 Sep 2025 – From PCR Rio Valves 2025

Welcome to PCR Rio Valves 2025, the premier event dedicated to advancements in structural heart interventions. This session sets the stage for an engaging congress filled with cutting-edge research, expert discussions, and innovative valve therapies shaping the future of cardiology.

Welcome to PCR Rio Valves 2025

News regarding the SIRONA Randomized Trial

10 Feb 2022

EuroPCR 2024: Primary outcomes from PINNACLE I clinical trial establish safety and effectiveness of Elixir Medical’s Hertz Contact Intravascular Lithotripsy System for calcium fragmentation in moderate to severe calcified coronary artery lesions

16 May 2024

TRILUMINATE pivotal: A landmark randomized clinical trial of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation

04 Mar 2023

Jonathan Curio and Alex Sticchi provide their take on this clinical trial which was presented by Paul Sorajja at the American College of Cardiology Scientific Session (ACC.23/WCC).

Alessandro Sticchi

Author

Alessandro Sticchi
Jonathan Curio

Author

Jonathan Curio
Live from ACC.23/WCC: TRILUMINATE pivotal

BioCardia reports positive interim results from phase III CardiAMP cell therapy heart failure trial, with compelling data in subgroup with elevated NTproBNP biomarker for heart failure.

04 Mar 2024

Didn’t find what you were looking for?